Biggest News Aggregation in the World
📰 Collaborative Group News

Page 17 - Collaborative Group News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Collaborative Group. Real-time updates on events, politics, business and more.

Agriculture Economic Development Grant Program -United States

Agriculture Economic Development Grant Program -United States 105SHARES Applications are now open for “ Agriculture Economic Development” grant program that will assist local farmers to develop new sources of agricultural income through the provision of cost-share grants. Applicants must be able to demonstrate that their operation is a verifiable farm business. The farm tract and farming operation on which the funds are to be used must be in Orange County. The maximum amount any one farm ca...
Economic Development Department Agriculture Economic Development Grant Subcommittee Agriculture Economic Development Collaborative Group Orange County Economic Development Department Premium Membership

TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer

TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer Approval based on unprecedented results from the ADAURA Phase III trial where TAGRISSO WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s TAGRISSO ® (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumor resection with curative intent. TAGRISS...
United States United Kingdom Dave Fredrickson Roys Herbst Le Chevalier American Society Of Clinical Oncology

ADDING MULTIMEDIA TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer

ADDING MULTIMEDIA TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer Approval based on unprecedented results from the ADAURA Phase III trial where TAGRISSO WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s TAGRISSO ® (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumor resection with curati...
United States United Kingdom Dave Fredrickson Roys Herbst Le Chevalier American Society Of Clinical Oncology

Tagrisso approved in the US for the adjuvant treatment of patients...

AstraZeneca’s Tagrisso (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumour resection with curative intent. Tagrisso is indicated for EGFRm patients whose tumours have exon 19 deletions or exon 21 L858R mutations as detected by an approved test. The approval was granted under the US Food and Drug Administration’s (FDA) Real-Time Oncology Revie...
United States United Kingdom Dave Fredrickson Thorac Onc Astrazeneca Tagrisso Roys Herbst

Lower PEEP an Option in Non-ARDS Patients | Physician's Weekly

Dec 11, 2020 But study used non-standard PEEP ventilation strategy A ventilation strategy with lower positive end-expiratory pressure (PEEP) held its own against a higher-PEEP strategy in patients without acute respiratory distress syndrome (ARDS) according to researchers in the Netherlands, although Canadian experts pointed out that neither strategy was in line with standard care. In the non-inferiority trial performed at eight ICUs, “patients randomized to the lower PEEP strategy had a medi...
Noord Holland Shalmali Pal Marcusj Schultz Arthurs Slutsky Collaborative Group Amsterdam University Medical Centers

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Ohio State announces passing of longtime cancer genetics researcher Albert de la Chapelle

Ohio State announces passing of longtime cancer genetics researcher Albert de la Chapelle His work helped lead to the statewide Ohio Colorectal Cancer Prevention Initiative The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has announced the passing of Dr. Albert de la Chapelle, a Distinguished University Professor in the Department of Cancer Biology and Genetics at Ohio State who played a key ro...
United States Ohio State University Arthurg James Clarad Bloomfield Ohio Colorectal Cancer Prevention Initiative Ohio State University Comprehensive Cancer Center
Source: osu.edu

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science